Xconomy

SEPTEMBER 11, 2019

GlaxoSmithKline is acquiring a startup it helped launch in 2013 as part of an alliance with life sciences venture capital firm Avalon Ventures. Avalon said Tuesday that GSK (NYSE: GSK ) has agreed to buy the company, Sitari Pharmaceuticals, which has been developing a treatment for celiac disease.

Avalon 56

Avalon Invest Southern California Develop 56

Xconomy

AUGUST 17, 2016

San Diego’s Avelas Biosciences , founded in 2009 to advance a fluorescing biologic agent intended to help surgeons differentiate cancerous tissue from healthy tissue, has completed a $20 million Series C round of venture funding. and San Diego’s Avalon Ventures. He is the CEO and managing partner at Inbio Ventures.

Avalon 40

Avalon San Diego Study Invest 40

Xconomy

AUGUST 30, 2017

Investment in experimental drugs for hearing loss, long an untapped field in the pharmaceutical industry, may be picking up, but drugs that actually help with these disorders remain elusive.

San Diego 59

San Diego Invest Help Develop 59

Xconomy

JANUARY 26, 2017

As has been the case for biotechs over the past year , insiders helped Anaptys get to the public market. Stockholders who had invested in the. Anaptys also sold 1 million more shares that it had initially planned. Read more » Reprints | Share: UNDERWRITERS AND PARTNERS.

Marketing 40

Marketing San Diego Invest Help 40